SPG
48
2
ADT
50
2
PNR
51
3
ALL
56
2
RSG
47
2
ALLE
44
3
A
43
-5
EFX
54
2
HRB
46
4
MRK
63
3
CAG
41
-5
VTR
67
-3
ROK
47
4
PYPL
52
2
AVB
34
-3
MCK
67
3
AVGO
54
12
PGR
42
2
CCI
36
2
AVY
47
-7
SPG
48
2
ADT
50
2
PNR
51
3
ALL
56
2
RSG
47
2
ALLE
44
3
A
43
-5
EFX
54
2
HRB
46
4
MRK
63
3
CAG
41
-5
VTR
67
-3
ROK
47
4
PYPL
52
2
AVB
34
-3
MCK
67
3
AVGO
54
12
PGR
42
2
CCI
36
2
AVY
47
-7
Financhill
Back

Calamos Dynamic Convertible and Income Fund Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
45

CCD
Calamos Dynamic Convertible and Income Fund

Last Price:
$21.39
Seasonality Move:
-2.01%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
45
Calamos Dynamic Convertible and Income Fund (CCD) is a Sell

Is Calamos Dynamic Convertible and Income Fund a Buy, Sell or Hold?

  • The current Calamos Dynamic Convertible and Income Fund [CCD] share price is $21.39. The Score for CCD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CCD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CCD Stock Price Chart

What is Calamos Dynamic Convertible and Income Fund's stock price today?

  • The Calamos Dynamic Convertible and Income Fund share price today is $21.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

CCD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 53.71 Buy
Chaikin Money Flow: 101173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.57 - 21.47) Buy
Bollinger Bands (100): (20.56 - 21.64) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

CCD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.16 Buy
20-day SMA: 21.16 Buy
50-day SMA: 21.34 Buy
200-day SMA: 21 Buy
8-day EMA: 21.1 Buy
20-day EMA: 21.17 Buy
50-day EMA: 20.84 Buy
200-day EMA: 13.45 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

Calamos Dynamic Convertible and Income Fund Earnings Growth & CCD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Calamos Dynamic Convertible and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):